Community post
Avatar
XimenaG • Admin
Multiple Myeloma Discussion • November 10
🚨Breaking Myeloma News: Darzalex Approved for High-Risk Smoldering Myeloma
🚨Breaking Myeloma News The FDA has approved Darzalex Faspro (daratumumab + hyaluronidase) as the first treatment for adults with high-risk smoldering multiple myeloma. This approval marks a major step toward earlier intervention and better outcomes. 🧬 Learn more: https://healthtree.org/myeloma/community/articles/25-daratumumab-darzalex-faspro-hrsmm?utm_source=social_media&utm_medium=meta&utm_campaign=socialmediaorganic&utm_content=general #WeCareWeCure #Myeloma #FDANews #BloodCancerResearch
FDA Approves Daratumumab for High-Risk SMM - HealthTree for Multiple Myeloma

FDA Approves Daratumumab for High-Risk SMM - HealthTree for Multiple Myeloma

First ever drug approval for high-risk smoldering myeloma is a combination of daratumumab and hyaluronidase-fihj (Darzalex Faspro, J&J)

https://healthtree.org/myeloma/community/articles/25-daratumumab-darzalex-faspro-hrsmm?utm_source=social_media&utm_medium=meta&utm_campaign=socialmediaorganic&utm_content=general
Avatar

No comments yet.

Related Content